Evaluation of Oxygen Delivery Methods in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

April 30, 2024

Study Completion Date

June 1, 2024

Conditions
Chronic Obstructive Pulmonary Disease Exacerbation
Interventions
DEVICE

EzPAP®

EzPAP® is a portable, single-use respiratory exercise device that provides positive expiratory pressure during expiration while supporting respiration during inspiration. Its use has been increasing in recent years as an oxygenation device. It is portable, single-use, easy to use, well-tolerated, and cost-effective. EzPAP® helps increase functional capacity in the lungs and reduces atelectasis. With EzPAP®, an oxygen flow of 5-8 L/min reaches the patient as 35-42% fractionated oxygen, thus quadrupling the oxygen flow.

DEVICE

Non-invasive mechanical ventilation (NIMV)

NIMV provides respiratory support during both expiration and inspiration through continuous positive airway pressure (CPAP) or bi-level positive airway pressure (BiPAP). Treatment success can be monitored within the first 2 hours by the improvement in oxygenation and reduction in pCO2 levels

Trial Locations (1)

38000

Ankara Etlik City Hospital, Ankara

All Listed Sponsors
lead

Ankara Etlik City Hospital

OTHER_GOV

NCT06561464 - Evaluation of Oxygen Delivery Methods in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter | Biotech Hunter